Genetically engineered biomimetic ATP-responsive nanozyme for the treatment of cardiac fibrosis

Genetically engineered biomimetic ATP-responsive nanozyme for the treatment of cardiac fibrosis

Abstract Background Cardiac fibrosis plays a critical role in the progression of various forms of heart disease, significantly increasing the risk of sudden cardiac death. However, currently, there are no therapeutic strategies available to prevent the onset of cardiac fibrosis. Methods and results...

Full description

Saved in:
Bibliographic Details
Main Authors: Xueli Zhao, Yuze Qin, Bowen Li, Yue Wang, Jiao Liu, Bo Wang, Jia Zhao, Jiaqi Yin, Lanlan Zhang, Jing Li, Junzhe Huang, Kun Chen, Liwen Liu, Yuanming Wu
Format: Article
Language:English
Published: BMC 2025-01-01
Series:Journal of Nanobiotechnology
Subjects:
Cardiac fibrosis
Zeolitic imidazole frameworks-90
Nanozyme
ATP-responsive
Genetically engineered
Online Access:https://doi.org/10.1186/s12951-024-03083-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12951-024-03083-2

Similar Items